Skip to main content
SANTEN PHARMACEUTICAL CO.,LTD. logo

SANTEN PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4536 ISIN · JP3336000009 LEI · 529900TPT3I7C17MIM03 T Manufacturing
Filings indexed 78 across all filing types
Latest filing 2016-06-24 Annual Report
Country JP Japan
Listing T 4536

About SANTEN PHARMACEUTICAL CO.,LTD.

https://www.santen.com/en

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Recent filings

Filing Released Lang Actions
有価証券報告書-第104期(2015/04/01-2016/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains detailed financial statements, management indicators, and corporate information for the fiscal year ending March 31, 2016. The document structure, including the cover page and the 'Part 1: Corporate Information' section, confirms it is the official annual filing submitted to the Kanto Local Finance Bureau. FY 2016
2016-06-24 Japanese
四半期報告書-第104期第3四半期(2015/10/01-2015/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Santen Pharmaceutical Co., Ltd. for the third quarter of the 104th fiscal period (ending December 31, 2015). It contains detailed financial statements, management analysis of financial results, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2016
2016-02-05 Japanese
四半期報告書-第104期第2四半期(2015/07/01-2015/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Santen Pharmaceutical Co., Ltd. for the second quarter of the 104th fiscal period (July 1, 2015 to September 30, 2015). It contains detailed financial statements, management analysis (MDA), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2016
2015-11-06 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.